J-Holdings
2721
Techpoint
6697
CCReB Advisors
276A
Renascience
4889
Green Monster
157A
JP Stock MarketDetailed Quotes
4598 Delta-Fly Pharma
- 514
- -14-2.65%
20min DelayNot Open Jan 16 15:30 JST
4.75BMarket Cap-2.59P/E (Static)
548High513Low237.00KVolume536Open528Pre Close123.98MTurnover92952wk High3.27%Turnover Ratio9.24MShares44552wk Low-218.3EPS TTM3.73BFloat Cap5380Historical HighLossP/E (Static)7.25MShs Float445Historical Low-198.78EPS LYR6.63%Amplitude--Dividend TTM14.68P/B100Lot Size--Div YieldTTM
Delta-Fly Pharma News
Delta-Fly Pharma: Confirmatory letter.
Delta-Fly Pharma: Half Year Report - Term 15 (2024/04/01 - 2025/03/31)
Delta-Fly Pharma: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: 2Q financial results presentation materials for the fiscal year ending 2025/3 20241114
Delta-Fly Pharma: Extraordinary Report
Delta-Fly Pharma: Extraordinary Report
Delta-Fly Pharma: Supplementary materials for Q1 financial results for March 2025.
Delta-Fly Pharma: Short statement of financial results for Q1 in March 2025 (based on Japanese standards, non-consolidated).
Delta-Fly Pharma: Interim report
Delta-Fly Pharma: Confirmatory letter.
Delta-Fly Pharma: Securities report - 14th period (April 01, 2023 - March 31, 2024)
DELTA FLY PHARMA: Financial results presentation materials for the fiscal year ending 2024/3 20240515
DELTA FLY PHARMA: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: Confirmation Letter
Delta-Fly Pharma: Quarterly Report - 14th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
Delta-Fly Pharma: Supplemental financial results for the 3rd quarter of the fiscal year ending March 31, 2024
Delta-Fly Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: (Correction) Partial correction to “Supplementary Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024”
Delta-Fly Pharma: Confirmation letter
Delta-Fly Pharma: Quarterly Report - 14th Second Quarter (2023/07/01 - 2023/09/30)